Antiplaque/antigingivitis OTC product combinations endorsed by Plaque Subcommittee.
This article was originally published in The Tan Sheet
Executive Summary
ANTIPLAQUE/ANTIGINGIVITIS OTC COMBINATION POLICY ENDORSED by FDA's Dental Plaque Subcommittee at its meeting in Gaithersburg, Md. May 29. The subcommittee recommended that anticaries and tooth desensitizing agents appropriately could be combined with an approved antiplaque/antigingivitis ingredient or ingredient combination.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning